Sanctions And Export Control Risks For Health Care Cos.
Over the past 15 years, pharmaceutical manufacturers, medical device companies and other participants in the health care industry have been regular targets of U.S. Foreign Corrupt Practices Act enforcement actions brought...To view the full article, register now.
Already a subscriber? Click here to view full article